A Look Back at 2017 Lends an Optimistic View of the Year Ahead
Posted on January 29, 2018 by Pete Kissinger
Since reengaging with BASi in 2017, I've seen positive trends that matter for 2018. We've had four consecutive quarters with positive earnings after a rough decade with both a slowly recovering economy and ongoing restructuring of the biopharma industry. Investing in growth is a priority. It is well recognized that life science innovation is very healthy, with new initiatives taking hold in editing out genetic abnormalities and marshaling the immune system to help root out a variety of cancers. The FDA approved many new therapies in 2017 and now promises to ease the way to more.
It’s always nice to be recognized for your achievements. It’s even better when your passion and commitment are the driving forces behind your success, and any accolades are truly just a bonus. For BASi founder and scientific advisor, Pete Kissinger, a long and varied career in science and research has always been rooted in the pursuit of better bioanalytical data for better decisions and ultimately, better patient care.
As a company that’s been around for over 42 years, we’ve held a front-row seat to the unrelenting demands for innovation, and continuously strive to meet and surpass those demands as the contract research industry evolves. Keeping pace with new technologies and instrumentation is essential to our work and to the success of our clients, partners and ultimately, patients waiting for treatment.
It’s always gratifying to hear how our clients and partners are using BASi products to conduct their studies and propel their research forward. Recently, Paul Moore, Director and Professor of Biological Studies at Bowling Green State University, wrote to us about his research using the tried and true BASi EC Epsilon electrochemical analyzer.
He's Back! Q&A with BASi Founder, Pete Kissinger, Who's Returned as Scientific Advisor
Posted on October 18, 2017 by Kimberly Beaty
Awesome things are happening at BASi, not the least of which is the return of our founder, Peter T. Kissinger, as a Scientific Advisor to the company. And what better way to launch our new blog, BASiBroadcast, than a Q&A session with Pete about his thoughts on the ever-evolving pharmaceutical industry and being back at BASi during this exciting time.